Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tight versus usual glycaemic control after allogeneic stem cell transplantation
2014-004418-27Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- Mar 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin glargine and insulin aspart in hyperglycemia (2 arms), sponsored by Medical University of Graz. Primary endpoints: Feasibility of tight glycaemic control using GlucoTab, Complication rate data for planning definitive trial and 1 more. Started Mar 2015; status: completed.
02
Drugs
insulin glargineinsulin aspart
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on 2014-004418-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004418-27.